| As Of | Filing | | Doc. | | Page | | Title | Docs. |
|---|
| | |  |
| 2/1/24 | | F-1 | | | | 1 | | Business | 6 |
| | | | | | 1 | | Capitalization | 6 |
| | | | | | 1 | | Consolidated Balance Sheets as of December 31, 2021 and 2022 | 6 |
| | | | | | 1 | | Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2022 | 6 |
| 7/26/23 | | DRS/A | | | | 1 | | Consolidated Statements of Changes in Owners' Deficit for the years ended December 31, 2021 and 2022 | 2 |
| 2/1/24 | | F-1 | | | | 1 | | Consolidated Statements of Changes in Shareholders' Deficit for the years ended December 31, 2021 and 2022 | 4 |
| | | | | | 1 | | Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2021 and 2022 | 6 |
| | | | | | 1 | | Conventions Which Apply to This Prospectus | 6 |
| | | | | | 1 | | Corporate History and Structure | 6 |
| | | | | | 1 | | Description of American Depositary Shares | 6 |
| | | | | | 1 | | Description of Share Capital | 6 |
| | | | | | 1 | | Dilution | 6 |
| | | | | | 1 | | Dividend Policy | 6 |
| | | | | | 1 | | Enforceability of Civil Liabilities | 6 |
| | | | | | 1 | | Expenses Related to This Offering | 6 |
| | | | | | 1 | | Experts | 6 |
| | | | | | 1 | | F-1 | 6 |
| | | | | | 1 | | F-2 | 6 |
| | | | | | 1 | | F-3 | 6 |
| 7/26/23 | | DRS/A | | | | 1 | | F-32 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | F-36 | 4 |
| | | | | | 1 | | F-37 | 4 |
| | | | | | 1 | | F-38 | 4 |
| | | | | | 1 | | F-39 | 4 |
| | | | | | 1 | | F-4 | 5 |
| | | | | | 1 | | F-40 | 4 |
| | | | | | 1 | | F-41 | 4 |
| | | | | | 1 | | F-5 | 6 |
| 10/6/23 | | DRS/A | | | | 1 | | F-51 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | F-6 | 6 |
| | | | | | 1 | | F-7 | 6 |
| | | | | | 1 | | F-8 | 6 |
| | | | | | 1 | | Ii-1 | 6 |
| 6/2/23 | | DRS | | | | 1 | | Ii-3 | 1 |
| 7/26/23 | | DRS/A | | | | 1 | | Ii-6 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | Ii-7 | 4 |
| | | | | | 1 | | Implications of Being An Emerging Growth Company | 6 |
| | | | | | 1 | | Index to the Consolidated Financial Statements | 6 |
| | | | | | 1 | | Industry | 6 |
| | | | | | 1 | | Legal Matters | 6 |
| | | | | | 1 | | Management | 6 |
| | | | | | 1 | | Management's Discussion and Analysis of Financial Condition and Results of Operations | 6 |
| | | | | | 1 | | Notes to the Consolidated Financial Statements | 6 |
| | | | | | 1 | | Notes to the Unaudited Condensed Consolidated Financial Statements | 4 |
| | | | | | 1 | | Offering, The | 6 |
| | | | | | 1 | | Our Summary Consolidated Financial Data | 6 |
| | | | | | 1 | | Part Ii Information Not Required in the Prospectus | 6 |
| | | | | | 1 | | Powers of Attorney (included on signature page) | 1 |
| | | | | | 1 | | Principal Shareholders | 6 |
| | | | | | 1 | | Prospectus Summary | 6 |
| | | | | | 1 | | Regulation | 6 |
| | | | | | 1 | | Related Party Transactions | 6 |
| | | | | | 1 | | Report of Independent Registered Public Accounting Firm | 6 |
| | | | | | 1 | | Risk Factors | 6 |
| | | | | | 1 | | Selected Consolidated Historical Financial Information | 6 |
| | | | | | 1 | | Shares Eligible for Future Sale | 6 |
| | | | | | 1 | | Special Note Regarding Forward-Looking Statements and Industry Data | 6 |
| | | | | | 1 | | Table of Contents | 6 |
| | | | | | 1 | | Taxation | 6 |
| | | | | | 1 | | The Offering | 6 |
| 10/6/23 | | DRS/A | | | | 1 | | Unaudited Condensed Consolidated Balance Sheets as of December 31, 2022 and June 30, 2023 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | Unaudited Condensed Consolidated Balance Sheets as of December 31, 2022 and September 30, 2023 | 1 |
| | | | | | 1 | | Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2023 | 1 |
| 10/6/23 | | DRS/A | | | | 1 | | Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2022 and 2023 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Nine Months Ended September 30, 2022 and 2023 | 1 |
| 10/6/23 | | DRS/A | | | | 1 | | Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Six Months Ended June 30, 2022 and 2023 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | Underwriting | 6 |
| | | | | | 1 | | Use of Proceeds | 6 |
| | | | | | 1 | | Where You Can Find Additional Information | 6 |
| | | | | | 1 | | Xchg Limited Exhibit Index | 6 |
| 6/2/23 | | DRS | | | | 1 | | 103 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | 104 | 1 |
| 6/2/23 | | DRS | | | | 1 | | 105 | 1 |
| 7/26/23 | | DRS/A | | | | 1 | | 106 | 2 |
| 10/6/23 | | DRS/A | | | | 1 | | 112 | 4 |
| 7/26/23 | | DRS/A | | | | 1 | | 114 | 1 |
| | | | | | 1 | | 116 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | 117 | 2 |
| 10/6/23 | | DRS/A | | | | 1 | | 118 | 3 |
| | | | | | 1 | | 120 | 3 |
| | | | | | 1 | | 121 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | 123 | 1 |
| 6/2/23 | | DRS | | | | 1 | | 125 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | 126 | 1 |
| 6/2/23 | | DRS | | | | 1 | | 127 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | 128 | 1 |
| 7/26/23 | | DRS/A | | | | 1 | | 130 | 1 |
| 6/2/23 | | DRS | | | | 1 | | 133 | 1 |
| 10/6/23 | | DRS/A | | | | 1 | | 135 | 3 |
| 7/26/23 | | DRS/A | | | | 1 | | 138 | 1 |
| | | | | | 1 | | 140 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | 142 | 1 |
| 10/6/23 | | DRS/A | | | | 1 | | 143 | 3 |
| | | | | | 1 | | 145 | 3 |
| 7/26/23 | | DRS/A | | | | 1 | | 146 | 2 |
| 6/2/23 | | DRS | | | | 1 | | 147 | 1 |
| | | | | | 1 | | 148 | 1 |
| | | | | | 1 | | 149 | 1 |
| 2/1/24 | | F-1 | | | | 1 | | 150 | 1 |
| 10/6/23 | | DRS/A | | | | 1 | | 151 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | 152 | 1 |
| | | | | | 1 | | 158 | 1 |
| 7/26/23 | | DRS/A | | | | 1 | | 159 | 1 |
| | | | | | 1 | | 160 | 1 |
| | | | | | 1 | | 161 | 1 |
| | | | | | 1 | | 162 | 1 |
| 10/6/23 | | DRS/A | | | | 1 | | 164 | 3 |
| | | | | | 1 | | 165 | 3 |
| | | | | | 1 | | 166 | 3 |
| | | | | | 1 | | 167 | 3 |
| 2/1/24 | | F-1 | | | | 1 | | 171 | 1 |
| | | | | | 1 | | 172 | 1 |
| | | | | | 1 | | 173 | 1 |
| | | | | | 1 | | 174 | 1 |
